does hers prescribe tirzepatide Hims & to sell Lilly's weight-loss drug on its telehealth platform Hims & Hers Expands Weight

This is a different situation from the lyophilized form

Tirzepatide which targets both GLP-1 and GIP receptors has shown even more dramatic early results: weight loss of 1020 kg and insulin dose reductions exceeding 30% in observational and phase 2 data, with improved CGM time in range

They do not require MHRA pre-market approval

Follow-up studies and disease registries will be essential to determine whether such benefits translate into lower CKD progression rates or cancer incidence in MASH cohorts

Go to the ER if you experience decreased urination, swelling in the ankles or legs, fatigue, or shortness of breath

This story was originally published July 8, 2024